The scRNA-seq analyses revealed alterations in specific cell subpopulations (including SPP1+ macrophages, myofibroblasts and IgG+ plasma cells) related to KRAS mutation and suggested the roles of genetic alterations in tumor cells that determine the formation of these unique tumor microenvironments in CRC. This evidence concerns the gene KRAS and colorectal carcinoma.